BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17908797)

  • 21. Interleukin-1 controls the constitutive expression of the Cyp7a1 gene by regulating the expression of Cyp7a1 transcriptional regulators in the mouse liver.
    Kojima M; Ashino T; Yoshida T; Iwakura Y; Degawa M
    Biol Pharm Bull; 2011; 34(10):1644-7. PubMed ID: 21963511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of the alternatively spliced nuclear receptor coactivator-6 isoforms.
    Li Q; Xu J
    Int J Biol Sci; 2011 Apr; 7(5):505-16. PubMed ID: 21552418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear receptor coactivator thyroid hormone receptor-binding protein (TRBP) interacts with and stimulates its associated DNA-dependent protein kinase.
    Ko L; Chin WW
    J Biol Chem; 2003 Mar; 278(13):11471-9. PubMed ID: 12519782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in mice.
    Zhang H; Liao L; Kuang SQ; Xu J
    Endocrinology; 2003 Apr; 144(4):1435-43. PubMed ID: 12639927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRRAP as a hepatic coactivator of LXR and FXR function.
    Unno A; Takada I; Takezawa S; Oishi H; Baba A; Shimizu T; Tokita A; Yanagisawa J; Kato S
    Biochem Biophys Res Commun; 2005 Feb; 327(3):933-8. PubMed ID: 15649435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of the nuclear receptor coactivator RAP250 in mice results in placental vascular dysfunction.
    Antonson P; Schuster GU; Wang L; Rozell B; Holter E; Flodby P; Treuter E; Holmgren L; Gustafsson JA
    Mol Cell Biol; 2003 Feb; 23(4):1260-8. PubMed ID: 12556486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
    J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.
    Chang Cy; Norris JD; Grøn H; Paige LA; Hamilton PT; Kenan DJ; Fowlkes D; McDonnell DP
    Mol Cell Biol; 1999 Dec; 19(12):8226-39. PubMed ID: 10567548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model.
    Hashimoto K; Cohen RN; Yamada M; Markan KR; Monden T; Satoh T; Mori M; Wondisford FE
    J Biol Chem; 2006 Jan; 281(1):295-302. PubMed ID: 16260782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells.
    Kim MS; Sweeney TR; Shigenaga JK; Chui LG; Moser A; Grunfeld C; Feingold KR
    Metabolism; 2007 Feb; 56(2):267-79. PubMed ID: 17224343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor- and liver X receptor alpha-controlled metabolic pathways in mice.
    Herrema H; Meissner M; van Dijk TH; Brufau G; Boverhof R; Oosterveer MH; Reijngoud DJ; Müller M; Stellaard F; Groen AK; Kuipers F
    Hepatology; 2010 Mar; 51(3):806-16. PubMed ID: 19998408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic expression of CYP7A1 in LDL receptor-deficient mice blocks diet-induced hypercholesterolemia.
    Ratliff EP; Gutierrez A; Davis RA
    J Lipid Res; 2006 Jul; 47(7):1513-20. PubMed ID: 16609145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis.
    Jiang W; Miyamoto T; Kakizawa T; Nishio SI; Oiwa A; Takeda T; Suzuki S; Hashizume K
    Biochem Biophys Res Commun; 2006 Dec; 351(1):176-84. PubMed ID: 17054913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lipoprotein/lipid profile is modulated by a gene-diet interaction effect between polymorphisms in the liver X receptor-alpha and dietary cholesterol intake in French-Canadians.
    Robitaille J; Houde A; Lemieux S; Gaudet D; Pérusse L; Vohl MC
    Br J Nutr; 2007 Jan; 97(1):11-8. PubMed ID: 17217555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis.
    Tobin KA; Ulven SM; Schuster GU; Steineger HH; Andresen SM; Gustafsson JA; Nebb HI
    J Biol Chem; 2002 Mar; 277(12):10691-7. PubMed ID: 11781314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) promoter by fibrates in cultured cells is mediated via the liver x receptor alpha and peroxisome proliferator-activated receptor alpha heterodimer.
    Gbaguidi GF; Agellon LB
    Nucleic Acids Res; 2004; 32(3):1113-21. PubMed ID: 14960721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
    Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
    J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activating signal cointegrator-2 is an essential adaptor to recruit histone H3 lysine 4 methyltransferases MLL3 and MLL4 to the liver X receptors.
    Lee S; Lee J; Lee SK; Lee JW
    Mol Endocrinol; 2008 Jun; 22(6):1312-9. PubMed ID: 18372346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypolipidemic effects of selective liver X receptor alpha agonists.
    Song C; Liao S
    Steroids; 2001 Sep; 66(9):673-81. PubMed ID: 11546555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.